Company News

Galderma Gains Full Rights To Distribute Restylane

Expands footprint with more brands from Valeant.

Author Image

By: Christine Esposito

Editor-in-Chief

Galderma S.A. has gained full rights to distribute Restylane, Perlane, Emervel, Sculptra and Dysport from Valeant Pharmaceuticals International, Inc. The expansion into aesthetic and corrective dermatology in the US and Canada completes Galderma's global skin health footprint and extends its leadership in aesthetic medicine worldwide, the company said. “We at Galderma are delighted to bring Restylane, Perlane, Emervel, and Dysport home in the U.S. and Canada as is the case in dozens ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters